Microbiology

  1. Transmission and Protection against Reinfection in the Ferret Model with the SARS-CoV-2 USA-WA1/2020 Reference Isolate

    1. Devanshi R. Patel
    2. Cassandra J. Field
    3. Kayla M. Septer
    4. Derek G. Sim
    5. Matthew J. Jones
    6. Talia A. Heinly
    7. Thomas H. Vanderford
    8. Elizabeth A. McGraw
    9. Troy C. Sutton

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222 Vaccine

    1. Yasunori Watanabe
    2. Luiza Mendonça
    3. Elizabeth R. Allen
    4. Andrew Howe
    5. Mercede Lee
    6. Joel D. Allen
    7. Himanshi Chawla
    8. David Pulido
    9. Francesca Donnellan
    10. Hannah Davies
    11. Marta Ulaszewska
    12. Sandra Belij-Rammerstorfer
    13. Susan Morris
    14. Anna-Sophia Krebs
    15. Wanwisa Dejnirattisai
    16. Juthathip Mongkolsapaya
    17. Piyada Supasa
    18. Gavin R. Screaton
    19. Catherine M. Green
    20. Teresa Lambe
    21. Peijun Zhang
    22. Sarah C. Gilbert
    23. Max Crispin

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Effect of Inactivation Methods on SARS-CoV-2 Virion Protein and Structure

    1. Emma K. Loveday
    2. Kyle S. Hain
    3. Irina Kochetkova
    4. Jodi F. Hedges
    5. Amanda Robison
    6. Deann T. Snyder
    7. Susan K. Brumfield
    8. Mark J. Young
    9. Mark A. Jutila
    10. Connie B. Chang
    11. Matthew P. Taylor

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. SARS-CoV-2 Envelope (E) protein interacts with PDZ-domain-2 of host tight junction protein ZO1

    1. Ariel Shepley-McTaggart
    2. Cari A. Sagum
    3. Isabela Oliva
    4. Elizabeth Rybakovsky
    5. Katie DiGuilio
    6. Jingjing Liang
    7. Mark T. Bedford
    8. Joel Cassel
    9. Marius Sudol
    10. James M. Mullin
    11. Ronald N. Harty

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Oral Delivery of SARS-CoV-2 DNA Vaccines Using Attenuated Salmonella typhimurium as a Carrier in Rat

    1. Dan Zhu
    2. Mengyue Mengyue
    3. Aaodeng Qimuge
    4. Bilige Bilige
    5. Tegexi Baiyin
    6. Temuqile Temuqile
    7. Shana Chen
    8. Siqin Borjigen
    9. Huricha Baigude
    10. Dezhi Yang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. A comparative analysis of SARS-CoV-2 antivirals in human airway models characterizes 3CL pro inhibitor PF-00835231 as a potential new treatment for COVID-19

    1. Maren de Vries
    2. Adil S Mohamed
    3. Rachel A Prescott
    4. Ana M Valero-Jimenez
    5. Ludovic Desvignes
    6. Rebecca O’Connor
    7. Claire Steppan
    8. Joseph C Devlin
    9. Ellie Ivanova
    10. Alberto Herrera
    11. Austin Schinlever
    12. Paige Loose
    13. Kelly Ruggles
    14. Sergei B Koralov
    15. Annaliesa S. Anderson
    16. Joseph Binder
    17. Meike Dittmann

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. The Preclinical Inhibitor GS441524 in Combination with GC376 Efficaciously Inhibited the Proliferation of SARS-CoV-2 in the Mouse Respiratory Tract

    1. Yuejun Shi
    2. Lei Shuai
    3. Zhiyuan Wen
    4. Chong Wang
    5. Yuanyuan Yan
    6. Zhe Jiao
    7. Fenglin Guo
    8. Zhen F. Fu
    9. Huanchun Chen
    10. Zhigao Bu
    11. Guiqing Peng

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Potent mouse monoclonal antibodies that block SARS-CoV-2 infection

    1. Youjia Guo
    2. Atsushi Kawaguchi
    3. Masaru Takeshita
    4. Takeshi Sekiya
    5. Mikako Hirohama
    6. Akio Yamashita
    7. Haruhiko Siomi
    8. Kensaku Murano

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody

    1. Conrad E. Z. Chan
    2. Shirley G. K. Seah
    3. De Hoe Chye
    4. Shane Massey
    5. Maricela Torres
    6. Angeline P. C. Lim
    7. Steven K. K. Wong
    8. Jacklyn J. Y. Neo
    9. Pui San Wong
    10. Jie Hui Lim
    11. Gary S. L. Loh
    12. Dongling Wang
    13. Jerome D. Boyd-Kirkup
    14. Siyu Guan
    15. Dipti Thakkar
    16. Guo Hui Teo
    17. Kiren Purushotorman
    18. Paul E. Hutchinson
    19. Barnaby E. Young
    20. Jenny G. Low
    21. Paul A. MacAry
    22. Hannes Hentze
    23. Venkateshan S. Prativadibhayankara
    24. Kantharaj Ethirajulu
    25. Jason E. Comer
    26. Chien-Te K. Tseng
    27. Alan D. T. Barrett
    28. Piers J. Ingram
    29. Trevor Brasel
    30. Brendon John Hanson

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Evolution and variation of 2019-novel coronavirus

    1. Chenglong Xiong
    2. Lufang Jiang
    3. Yue Chen
    4. Qingwu Jiang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 158 of 245 Next